Loading…
Loading grant details…
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | Van Andel Research Institute |
| Country | United States |
| Start Date | Apr 01, 2022 |
| End Date | Aug 31, 2025 |
| Duration | 1,248 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10918267 |
Project Summary/Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with limited treatment options that has a five-year survival rate of
Van Andel Research Institute
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant